Astrid M. Schut

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial.

Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial.

Journal: Nature medicine

Published: March 11, 2026

Voices of those recruiting: A qualitative study on barriers and enablers to women's participation in cardiovascular trials.

Voices of those recruiting: A qualitative study on barriers and enablers to women's participation in cardiovascular trials.

Journal: Atherosclerosis

Published: February 04, 2026

Heart failure patients with reduced or mildly reduced ejection fraction: baseline characteristics of the low-dose digoxin outcome DECISION trial.

Heart failure patients with reduced or mildly reduced ejection fraction: baseline characteristics of the low-dose digoxin outcome DECISION trial.

Journal: European journal of heart failure

Published: December 23, 2025

Impact of Female Underrepresentation in Trials Investigating Long-Term Pharmacologic Therapy after Acute Coronary Syndrome A Meta-analysis and Meta-regression.

Impact of Female Underrepresentation in Trials Investigating Long-Term Pharmacologic Therapy after Acute Coronary Syndrome A Meta-analysis and Meta-regression.

Journal: European heart journal. Acute cardiovascular care

Published: October 16, 2025

Impact of female underrepresentation in trials investigating long-term pharmacologic therapy after acute coronary syndrome: a meta-analysis and meta-regression.

Impact of female underrepresentation in trials investigating long-term pharmacologic therapy after acute coronary syndrome: a meta-analysis and meta-regression.

Journal: European heart journal. Acute cardiovascular care

Published: October 16, 2025

Sex differences in pharmacological treatment of heart failure: a meta-analysis of randomized trials.

Sex differences in pharmacological treatment of heart failure: a meta-analysis of randomized trials.

Journal: European heart journal

Published: August 18, 2025

Making a difference: describing and evaluating the impact of the Dutch CardioVascular Alliance.

Making a difference: describing and evaluating the impact of the Dutch CardioVascular Alliance.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: July 07, 2025

PENELOPE-CTRL: protocolised LDL-C lowering compared to real-world care in patients after myocardial infarction.

PENELOPE-CTRL: protocolised LDL-C lowering compared to real-world care in patients after myocardial infarction.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: April 30, 2025

PENELOPE 1-year follow-up: legacy effect of a short protocol-led LDL-C-lowering strategy in patients after myocardial infarction.

PENELOPE 1-year follow-up: legacy effect of a short protocol-led LDL-C-lowering strategy in patients after myocardial infarction.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: February 03, 2025

A comprehensive analysis of female participation in cardiovascular trials involving the WCN investigator network.

A comprehensive analysis of female participation in cardiovascular trials involving the WCN investigator network.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: January 31, 2025

Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane.

Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane.

Journal: Cardio-oncology (London, England)

Published: December 06, 2024

Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial.

Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial.

Journal: European journal of heart failure

Published: April 07, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026